Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Petra Pharma

Petra Pharma
2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$17M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of pharmaceutical drugs intended to treat cancer and metabolic diseases. The company is focused on creating enzyme targets that play a central role that play a central role in a variety of important cellular processes, including cell division, growth and developing drugs, enabling doctors to help for the treatment of cancer and metabolic diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 450 East 29th Street
  • Suite 506
  • New York, NY 10016
  • United States

+1 (646) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Petra Pharma’s full profile, request a free trial.

Petra Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Aug-2019 $17M 0000 Completed Startup
1. Early Stage VC (Series A) 06-Jan-2016 0000 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Petra Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Petra Pharma Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Samumed Private Equity-Backed San Diego, CA 000 00000 0000000 0000 00000
00000 000000000000 Venture Capital-Backed San Francisco, CA 00000 000000000 00000
000000 00000 Private Equity-Backed Durham, NC 00 00000 000000000000 00000
000000 00000000000 Venture Capital-Backed South San Francisco, CA 00 00000 000000000 00000
0000 00000000000 Formerly VC-backed Redwood City, CA 00 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Petra Pharma Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
180 Degree Capital Venture Capital Minority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Petra Pharma Executive Team (6)

Name Title Board
Seat
Contact
Info
Brian O'Callaghan Chief Executive Officer, President and Board Member
David Renas JD Chief Financial Officer
David McElligott Ph.D Chief Scientific Officer
Albert Yu MD Chief Medical Officer
Nathanael Gray Ph.D Scientific Co-Founder and Chairman SAB
You’re viewing 5 of 6 executives. Get the full list »

Petra Pharma Board Members (11)

Name Representing Role Since Contact
Info
Asish Xavier Ph.D Johnson & Johnson Innovation - JJDC Board Member 000 0000
Barbara Dalton Ph.D Pfizer Ventures Board Member 000 0000
James Sullivan Petra Pharma Board Member 000 0000
Jenna Foger Alexandria Venture Investments Board Member 000 0000
Joel Marcus JD Alexandria Venture Investments Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »